RTI Surgical, Inc., together with its subsidiaries, designs, develops, manufactures, and distributes biologic, metal, and synthetic implants worldwide. It processes donated human musculoskeletal and other tissues, as well as bovine and porcine animal tissues to produce allograft and xenograft implants by using its proprietary BIOCLEANSE, TUTOPLAST, and CANCELLE SP sterilization processes. The company's implants are used in the fields of sports medicine, general surgery, spine, orthopedic, trauma, and cardiothoracic procedures to repair and promote the natural healing of human bone and other human tissues; and to enhance surgical outcomes. It markets its products through its direct distribution force, as well as through a network of independent distributors. The company was formerly known as RTI Biologics, Inc. and changed its name to RTI Surgical, Inc. in July 2013. RTI Surgical, Inc. was founded in 1997 and is headquartered in Alachua, Florida.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Surgical appliances & supplies
Sub-IndustryHealth Care Supplies
SectorMedical
SymbolNASDAQ:RTIX
CUSIP74975N10
Phone386-418-8888
Debt
Debt-to-Equity Ratio0.31
Current Ratio3.81
Quick Ratio1.53
Price-To-Earnings
Trailing P/E Ratio96.00
Forward P/E Ratio48.00
P/E Growth3.2
Sales & Book Value
Annual Sales$279.56 million
Price / Sales1.09
Cash Flow$0.2685 per share
Price / Cash17.88
Book Value$2.99 per share
Price / Book1.61
Profitability
EPS (Most Recent Fiscal Year)$0.05
Net Income$6.27 million
Net Margins2.57%
Return on Equity2.49%
Return on Assets1.24%
Miscellaneous
Employees942
Outstanding Shares63,430,000
Market Cap$304.45
RTI Surgical (NASDAQ:RTIX) Frequently Asked Questions
What is RTI Surgical's stock symbol?
RTI Surgical trades on the NASDAQ under the ticker symbol "RTIX."
How were RTI Surgical's earnings last quarter?
RTI Surgical Inc (NASDAQ:RTIX) posted its quarterly earnings data on Thursday, May, 3rd. The medical equipment provider reported $0.01 EPS for the quarter, meeting analysts' consensus estimates of $0.01. The medical equipment provider had revenue of $69.89 million for the quarter, compared to analyst estimates of $68.70 million. RTI Surgical had a net margin of 2.57% and a return on equity of 2.49%. View RTI Surgical's Earnings History.
When is RTI Surgical's next earnings date?
What is the consensus analysts' recommendation for RTI Surgical?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for RTI Surgical in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
Who are some of RTI Surgical's key competitors?
Some companies that are related to RTI Surgical include CONSORT Med PLC/S (CSRMY), Invacare (IVC), Sientra (SIEN), Lakeland Industries (LAKE), Histogenics (HSGX), ConforMIS (CFMS), Rewalk Robotics (RWLK), COLLPLANT HOLDI/S (CLGN), NanoVibronix (NAOV), Precision Therapeutics (AIPT), Bionik Laboratories (BNKL), Allied Healthcare Products (AHPI) and Avitar (AVTI).
Who are RTI Surgical's key executives?
RTI Surgical's management team includes the folowing people:
- Mr. Camille I. Farhat, CEO, Pres & Director (Age 48)
- Mr. Jonathon M. Singer, Chief Financial & Admin. Officer and Corp. Sec. (Age 54)
- Mr. John N. Varela, Exec. VP of Global Operations (Age 51)
- Mr. Kevin D. Brandt, Chief Commercial Officer of Domestic Direct and Exec. VP (Age 52)
- Mr. Johannes Wynand Louw, VP of Fin. & Corp. Controller
Has RTI Surgical been receiving favorable news coverage?
Media stories about RTIX stock have trended somewhat positive this week, according to Accern Sentiment Analysis. Accern identifies positive and negative media coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. RTI Surgical earned a media sentiment score of 0.24 on Accern's scale. They also assigned news headlines about the medical equipment provider an impact score of 47.11 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company's share price in the immediate future.
Who are RTI Surgical's major shareholders?
RTI Surgical's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Hillman Co. (1.70%). Company insiders that own RTI Surgical stock include Camille Farhat, John N Varela, Jonathon M Singer, Kevin D Brandt, Mark Stolper, Nicholas J Valeriani, Shirley A Weis and Thomas Mceachin. View Institutional Ownership Trends for RTI Surgical.
Which major investors are selling RTI Surgical stock?
How do I buy shares of RTI Surgical?
Shares of RTIX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is RTI Surgical's stock price today?
One share of RTIX stock can currently be purchased for approximately $4.80.
How big of a company is RTI Surgical?
RTI Surgical has a market capitalization of $304.45 million and generates $279.56 million in revenue each year. The medical equipment provider earns $6.27 million in net income (profit) each year or $0.05 on an earnings per share basis. RTI Surgical employs 942 workers across the globe.
How can I contact RTI Surgical?
RTI Surgical's mailing address is 11621 RESEARCH CIRCLE, ALACHUA FL, 32615. The medical equipment provider can be reached via phone at 386-418-8888 or via email at [email protected]
MarketBeat Community Rating for RTI Surgical (NASDAQ RTIX)
MarketBeat's community ratings are surveys of what our community members think about RTI Surgical and other stocks. Vote "Outperform" if you believe RTIX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RTIX will underperform the S&P 500 over the long term. You may vote once every thirty days.
